1 – 10 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
- Contribution to journal › Article
- 2025
-
Mark
Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
- Contribution to journal › Article
-
Mark
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Gene expression-based identification of prognostic markers in lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Capturing breast cancers’ copy-number landscape in routine pathology : Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond
- Contribution to journal › Article
